By annette
The Swedish Institute for Health Economics participates at the 11th Asia-Pacific Breast Cancer Summit 2023 on May 4-6, 2023 in Singapore. Thomas Hofmarcher will present findings of an upcoming policy report on triple-negative breast cancer (TNBC) in the Asia-Pacific region. He will highlight the health-economic impact of TNBC on patients and society as well as …
By annette
PRIME-ROSE is a precision cancer medicine trial network and implementation initiative.The PRIME-ROSE vision is access to affordable precision cancer medicine that prolongs life at the best quality possible for all cancer patients. Read more
By annette
We are happy to announce that Dr Michael Willis from IHE is presenting a poster at this year’s annual meeting of the Swedish Health Economic Association (SHEA). The poster presents results from a literature review and assessment of published budget impact models (BIMs) for NSCLC. BIMs are an important basis for decision-making and should be …
By annette
The prevalence of pain has long been focused in haemophilia research but depression and anxiety are less studied. A Nordic collaboration has investigated national prescription drug data in more than 3000 Nordic persons with haemophilia and compared data patterns to population controls. The key study finding is a persistently higher use of pain, depression and …
By annette
Diabetes Two studies focusing on people with type 2 diabetes and established cardiovascular disease (eCVD) in Sweden have been published in the medical journal “Diabetes, Obesity and Metabolism”. The first study examines the burden of hospital-based care, work absence, associated costs and excess mortality in people with type 2 diabetes, with and without eCVD. The …
By annette
New global study on the value of precision medicine in oncology. Read more
By annette
In the lates issue of Haemophilia, IHE contributes with a publication on how to make indirect comparisons of FVIII replacement products for treatment of haemophilia A based on the area under the plasma level curve (AUC). Read more
By annette
Researchers from IHE report significant long-term improvements in blood pressure and other risk factors for cardiovascular disease among Swedish patients treated for hypertension via a novel digital therapeutics’ platform. Read more
By annette
In a newly published register study, researcher from IHE have investigated the economic burden of palmoplantar pustulosis (PPP) in Sweden. PPP is a chronic relapsing skin condition commonly occurring in combination with psoriasis vulgaris. Read more